BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 24915858)

  • 21. Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
    Weber T; Ohlhauser D; Hillenbrand A; Henne-Bruns D; Reske SN; Luster M
    Horm Metab Res; 2012 Nov; 44(12):904-8. PubMed ID: 22791600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance.
    Pagano L; Samà MT; Morani F; Prodam F; Rudoni M; Boldorini R; Valente G; Marzullo P; Baldelli R; Appetecchia M; Isidoro C; Aimaretti G
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):528-34. PubMed ID: 21575027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and significance of thyroid uptake detected by ¹⁸F-FDG PET.
    Ho TY; Liou MJ; Lin KJ; Yen TC
    Endocrine; 2011 Oct; 40(2):297-302. PubMed ID: 21505891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
    Basu S; Li G; Bural G; Alavi A
    Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Head and neck incidentalomas on positron emission tomographic scanning: ignore or investigate?
    Al-Hakami HA; Makis W; Anand S; Mlynarek A; Black MJ; Stern J; Payne RJ; Hier MP
    J Otolaryngol Head Neck Surg; 2011 Oct; 40(5):384-90. PubMed ID: 22420393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidental thyroid lesions on FDG-PET/CT: a prevalence study and proposition of management.
    Adas M; Adas G; Koc B; Ozulker F
    Minerva Endocrinol; 2015 Sep; 40(3):169-75. PubMed ID: 26205646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorine-18 fluorodeoxyglucose avid thyroid incidentalomas on PET/CT scan in cancer patients: how sinister are they?
    Hassan A; Riaz S; Zafar W
    Nucl Med Commun; 2016 Oct; 37(10):1069-73. PubMed ID: 27571130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review.
    Soelberg KK; Bonnema SJ; Brix TH; Hegedüs L
    Thyroid; 2012 Sep; 22(9):918-25. PubMed ID: 22827552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid incidentaloma detected by fluorodeoxyglucose positron emission tomography/computed tomography: practical management algorithm.
    Nilsson IL; Arnberg F; Zedenius J; Sundin A
    World J Surg; 2011 Dec; 35(12):2691-7. PubMed ID: 21989645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
    Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
    Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact.
    Bonabi S; Schmidt F; Broglie MA; Haile SR; Stoeckli SJ
    Eur Arch Otorhinolaryngol; 2012 Dec; 269(12):2555-60. PubMed ID: 22298251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
    Choi JY; Lee KS; Kim HJ; Shim YM; Kwon OJ; Park K; Baek CH; Chung JH; Lee KH; Kim BT
    J Nucl Med; 2006 Apr; 47(4):609-15. PubMed ID: 16595494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects.
    Kang KW; Kim SK; Kang HS; Lee ES; Sim JS; Lee IG; Jeong SY; Kim SW
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4100-4. PubMed ID: 12970270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDG-PET detected thyroid incidentalomas: need for further investigation?
    Are C; Hsu JF; Schoder H; Shah JP; Larson SM; Shaha AR
    Ann Surg Oncol; 2007 Jan; 14(1):239-47. PubMed ID: 17024553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas.
    King DL; Stack BC; Spring PM; Walker R; Bodenner DL
    Otolaryngol Head Neck Surg; 2007 Sep; 137(3):400-4. PubMed ID: 17765765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of parotid gland incidentalomas on (18)F-FDG PET/CT.
    Makis W; Ciarallo A; Gotra A
    Clin Imaging; 2015; 39(4):667-71. PubMed ID: 25888252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid incidentalomas on FDG PET/CT in patients with non-thyroid cancer - a large retrospective monocentric study.
    Kim H; Kim SJ; Kim IJ; Kim K
    Onkologie; 2013; 36(5):260-4. PubMed ID: 23689220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Proportion of Malignancy in Incidental Thyroid Lesions on 18-FDG PET Study: A Systematic Review and Meta-analysis.
    Nayan S; Ramakrishna J; Gupta MK
    Otolaryngol Head Neck Surg; 2014 Aug; 151(2):190-200. PubMed ID: 24759908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of dual-phase 18F-FDG PET in characterizing thyroid incidentalomas.
    Hsiao YC; Wu PS; Chiu NT; Yao WJ; Lee BF; Peng SL
    Clin Radiol; 2011 Dec; 66(12):1197-202. PubMed ID: 21907336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of multi-modality functional imaging in differentiation between benign and malignant thyroid
    Shi H; Yuan Z; Yang C; Zhang J; Liu C; Sun J; Ye X
    Clin Transl Oncol; 2019 Nov; 21(11):1561-1567. PubMed ID: 30924093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.